T. Rowe Price Associates’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

T. Rowe Price Associates’s Portfolio SZYM Stock Details SZYM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-28,200	Closed	-$57K	–	2572
2016 Q1	$57K	Hold	28,200	–	–	﹤0.01%	2464
2015 Q4	$70K	Buy	+28,200	New	+$83.6K	﹤0.01%	2454
2014 Q4	–	Sell	-1,070,020	Closed	-$7.98M	–	2590
2014 Q3	$7.98M	Buy	1,070,020 +1,100	+0.1%	+$10.3K	﹤0.01%	1363
2014 Q2	$12.6M	Sell	1,068,920 -65,540	-6%	-$699K	﹤0.01%	1258
2014 Q1	$13.2M	Sell	1,134,460 -9,900	-0.9%	-$116K	﹤0.01%	1234
2013 Q4	$12.5M	Sell	1,144,360 -2,040	-0.2%	-$20.1K	﹤0.01%	1227
2013 Q3	$12.3M	Sell	1,146,400 -7,700	-0.7%	-$87.7K	﹤0.01%	1213
2013 Q2	$13.5M	Buy	+1,154,100	New	+$11.5M	﹤0.01%	1176

T. Rowe Price Associates's SZYM Position: Q2 2016 in Review

T. Rowe Price Associates sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q2 2016, closing a stake of 28,200 shares — an estimated $57K sold.

T. Rowe Price Associates first reported a position in SZYM in Q2 2013 and held it in 8 quarters. The position peaked at $13.5M in Q2 2013. 0 funds tracked by Wall St. Rank hold SZYM as of Q2 2016.

T. Rowe Price Associates reported no remaining SOLAZYME INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
T. Rowe Price Associates sold 28,200 SOLAZYME INC COM STK (DE) shares in Q2 2016, an estimated $57K.
T. Rowe Price Associates first reported a position in SOLAZYME INC COM STK (DE) in Q2 2013 and held it in 8 quarters.
T. Rowe Price Associates's SOLAZYME INC COM STK (DE) position peaked at $13.5M in Q2 2013.
0 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q2 2016.

Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.